# Drug-drug Interaction Study With GLPG3667 and Midazolam in Healthy Subjects

> **NCT04736927** · PHASE1 · COMPLETED · sponsor: **Lakefront Biotherapeutics NV** · enrollment: 14 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** GLPG3667
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT04736927
- **Lead sponsor:** Lakefront Biotherapeutics NV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-15
- **Primary completion:** 2021-02-25
- **Final completion:** 2021-02-25
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2021-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04736927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04736927, "Drug-drug Interaction Study With GLPG3667 and Midazolam in Healthy Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04736927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*